Incannex Healthcare Inc.

For the period ended Jun 30, 2026. Filed Sep 25, 2026.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2026 · Filed Sep 25, 2026

IXHL$2.01-8.2%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Consolidated Balance Sheets as of June 30, 202 and

Consolidated Balance Sheets

	June 30,2026	June 30,2025
Assets
Current assets:
Cash and cash equivalents	$67,711	$15,039
Prepaid expenses and other assets	537	791
R&D tax incentive receivable	4,579	4,132
Total current assets	72,827	19,962
Property, plant and equipment, net	4	227
Investment in joint venture	51	-
Operating lease right-of-use assets, net	97	258
Total assets	$72,979	$20,447
Liabilities and stockholders’ equity
Current liabilities:
Trade and other payables	$1,158	$6,104
Accrued expenses and other current liabilities	272	696
Operating lease liabilities, current	62	184
Total current liabilities	1,492	6,984
Operating lease liabilities, non-current	34	74
Warrant liabilities	4,080	-
Total liabilities	5,606	7,058
Commitments and contingencies (Note 8)
Stockholders’ equity:
Common stock, $0.0001 par value – 800,000,000 shares authorized; 12,544,298 and 6,479,333 shares issued and outstanding at June 30, 2026 and 2025, respectively	38	20
Additional paid-in capital	247,769	174,049
Accumulated deficit	(176,858)	(157,556)
Foreign currency translation reserve	(3,576)	(3,124)
Total stockholders’ equity	67,373	13,389
Total liabilities and stockholders’ equity	$72,979	$20,447

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.